Literature DB >> 25374874

Sudden cardiac death, aborted, in healthy 34-year-old male.

Hitesh Shah1.   

Abstract

A 34-year-old male, non-hypertensive, non-diabetic, had a sudden onset of cardiac arrest, he was revived and then referred to a cardiologist at an advanced center for further care. His 2D echo revealed hypertrophic obstructive cardiomyopathy, all the other investigations were normal. His father was also found to have a similar condition however the father was asymptomatic. The patient underwent an automated implantable cardioverter-defibrillator implantation and was advised the necessary precautions and care.

Entities:  

Keywords:  Automated implantable cardioverter-defibrillator implantation; hypertrophic obstructive cardiomyopathy; sudden cardiac death

Year:  2014        PMID: 25374874      PMCID: PMC4209692          DOI: 10.4103/2249-4863.141652

Source DB:  PubMed          Journal:  J Family Med Prim Care        ISSN: 2249-4863


Introduction

A 34-year-old male, non-hypertensive, non-diabetic, had a sudden onset of cardiac arrest, he was revived and then referred to a cardiologist at an advanced center for further care. His 2D echo revealed hypertrophic obstructive cardiomyopathy (HOCM), all the other investigations were normal. His father was also found to have a similar condition; however, the father was asymptomatic. The patient underwent an automated implantable cardioverter-defibrillator (AICD) implant and was advised the necessary precautions and care.

Case Report

The present case is about a 34-year-old male presented in a small city hospital in India with c/o breathlessness and chest pain, and also complaining of cough since 4-5 days. Where he went into cardiac arrest and was resuscitated and then put on inotropes and antiarrhythmic. He was subsequently discharged with hemodynamically normal status. No H/O diabetes, hypertension, bronchial asthma.

On examination

S1 and S2 normal but systolic murmur III/IV was heard, murmur increased on standing and reduced on sitting. Rest all systems normal.

Investigations

Electrocardiogram series shows left ventricular hypertrophy, and promanent P waves [Figure 1].
Figure 1

Electrocardiogram series shows left ventricular hypertrophy, and prominent P waves

Electrocardiogram series shows left ventricular hypertrophy, and prominent P waves His coronary angiogram was done which was normal. Magnetic resonance imaging brain was normal. 2D Echo revealed left ventricular ejection fraction 60%, left ventricular hypertrophy and HOCM, mild mitral regurgitation [Figure 2].
Figure 2

2D Echo report showing hypertrophic obstructive cardiomyopathy with good ejection fraction

2D Echo report showing hypertrophic obstructive cardiomyopathy with good ejection fraction

Further course

He was referred to a cardiologist in an advanced center for further management. He underwent an AICD implantation under local anesthesia and was subsequently discharged with a follow-up schedule.

Discussion

Sudden cardiac death

The most common cause of Sudden cardiac death (SCD) in adults over the age of 30 is coronary artery atheroma. Although the most frequent cause of SCD is coronary artery disease, other causes include: Non-atherosclerotic coronary artery abnormalities Hypertrophy of ventricular myocardium Myocardial diseases and heart failure. Arrhythmogenic right ventricular cardiomyopathy Hypertrophic cardiomyopathy (HCM) Dilated cardiomyopathy Myocardial infarction.

HCM

Is a primary disease of the myocardium (the muscle of the heart) in which a portion of the myocardium is hypertrophied (thickened) without any obvious cause. It is perhaps best known as a leading cause of SCD in young athletes. The occurrence of HCM is a significant cause of sudden unexpected cardiac death in any age group and as a cause of disabling cardiac symptoms. Younger people are likely to have a more severe form of HCM. HCM is frequently asymptomatic until SCD, and for this reason some suggest routinely screening certain populations for this disease. Familial HCM is inherited as an autosomal dominant trait and is attributed to mutations in one of a number of genes that encode for one of the sarcomere proteins, as was the case in our patient.

The treatment modalities for HOCM range from

Medications, surgical myomectomy, alcohol septal ablation, ventricular pacing, cardiac transplantation.
  8 in total

1.  Sudden unexplained death: heritability and diagnostic yield of cardiological and genetic examination in surviving relatives.

Authors:  Hanno L Tan; Nynke Hofman; Irene M van Langen; Allard C van der Wal; Arthur A M Wilde
Journal:  Circulation       Date:  2005-07-05       Impact factor: 29.690

2.  Symptoms preceding sudden cardiac death in the young are common but often misinterpreted.

Authors:  Aase Wisten; Torbjörn Messner
Journal:  Scand Cardiovasc J       Date:  2005-07       Impact factor: 1.589

Review 3.  Sudden death from cardiac causes in children and young adults.

Authors:  R R Liberthson
Journal:  N Engl J Med       Date:  1996-04-18       Impact factor: 91.245

4.  Sudden death from asthma in 108 children and young adults.

Authors:  S C Tough; F H Green; J E Paul; D T Wigle; J C Butt
Journal:  J Asthma       Date:  1996       Impact factor: 2.515

5.  Sudden death in children and adolescents.

Authors:  C Wren; J J O'Sullivan; C Wright
Journal:  Heart       Date:  2000-04       Impact factor: 5.994

Review 6.  Sudden infant death syndrome.

Authors:  Rachel Y Moon; Rosemary S C Horne; Fern R Hauck
Journal:  Lancet       Date:  2007-11-03       Impact factor: 79.321

7.  Out-of-hospital cardiac arrest in the 1990's: a population-based study in the Maastricht area on incidence, characteristics and survival.

Authors:  J J de Vreede-Swagemakers; A P Gorgels; W I Dubois-Arbouw; J W van Ree; M J Daemen; L G Houben; H J Wellens
Journal:  J Am Coll Cardiol       Date:  1997-11-15       Impact factor: 24.094

8.  Sudden unexpected nontraumatic death in 54 young adults: a 30-year population-based study.

Authors:  W K Shen; W D Edwards; S C Hammill; K R Bailey; D J Ballard; B J Gersh
Journal:  Am J Cardiol       Date:  1995-07-15       Impact factor: 2.778

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.